Picture [LSA] – The Business Web Portal 650x89px
Person › Details

Shaun Foy (CRISPR Therapeutics AG (Nasdaq: CRSP))

Foy, Shaun (CRISPR Therapeutics 201404 CFO + Co-Founder + ERS Genomics CEO + Co-Founder before Nomura Phase4 Ventures)


Organisations Organisation CRISPR Therapeutics AG (Nasdaq: CRSP)
  Group CRISPR Therapeutics (Group)
  Former/major organisation Nomura Phase4 Ventures
  Today Phase4 Partners Ltd. (Phase4 Ventures)
  Group Phase4 Partners Ltd. (Phase4 Ventures)
Product Product CRISPR gene editing technology

Record changed: 2019-04-13


Picture [LSA] – The Business Web Portal 650x89px

More documents for Shaun Foy

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

» top